Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TRAX

First Tracks Biotherapeutics Inc

Last Close
May 01  •  10:44AM ET
20.40
Dollar change
-2.87
Percentage change
-12.33
%
Apr 29, 12:02 PMBullish analyst initiations with high price targets drive nearly 19% TRAX surge.
Index
-
P/E
-
EPS (ttm)
-
Insider Own
-
Shs Outstand
-
Perf Week
12.33%
Market Cap
-
Forward P/E
-
EPS next Y
-
Insider Trans
-
Shs Float
-
Perf Month
-
Enterprise Value
-
PEG
-
EPS next Q
-
Inst Own
-
Perf Quarter
-
Income
-
P/S
-
EPS this Y
-
Inst Trans
-
Perf Half Y
-
Sales
-
P/B
-
EPS next Y
-
ROA
-
Perf YTD
7.37%
Book/sh
-
P/C
-
EPS next 5Y
-
ROE
-
52W High
26.80 -23.88%
Perf Year
-
Cash/sh
-
P/FCF
-
EPS past 3/5Y
- -
ROIC
-
52W Low
14.79 37.93%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
- -
Gross Margin
-
Volatility
17.24% -
Perf 5Y
-
Dividend TTM
-
EV/Sales
-
EPS Y/Y TTM
-
Oper. Margin
-
ATR (14)
3.14
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
-
Sales Y/Y TTM
-
Profit Margin
-
RSI (14)
51.70
Dividend Gr. 3/5Y
- -
Current Ratio
-
EPS Q/Q
-
SMA20
-3.58%
Beta
-
Payout
-
Debt/Eq
-
Sales Q/Q
-
SMA50
-3.58%
Rel Volume
1.97
Prev Close
23.27
Employees
-
LT Debt/Eq
-
Earnings
-
SMA200
-3.58%
Avg Volume
338.17K
Price
20.40
IPO
Apr 06, 2026
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
153,253
Change
-12.33%
Date Action Analyst Rating Change Price Target Change
Apr-28-26Initiated H.C. Wainwright Buy $30
Apr-24-26Initiated Wedbush Outperform $30
Apr-24-26Initiated Leerink Partners Outperform $46
Apr-23-26Initiated JP Morgan Overweight $31
Apr-22-26Initiated Barclays Overweight $40
Apr-21-26Initiated UBS Buy $45